Dr. Stark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2959 Sharpsburg McCullum Rd
Newnan, GA 30265Phone+1 770-502-2000Fax+1 770-502-2049
Education & Training
Emory University School of MedicineFellowship, Rheumatology, 2006 - 2008- Emory University School of MedicineResidency, Internal Medicine, 2003 - 2006
Vanderbilt University School of MedicineClass of 2003
Certifications & Licensure
GA State Medical License 2006 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.Anna Sheahan, Suzanne Anjohrin, Robert Suruki, Jeffrey L Stark, Victor S Sloan
Clinical Rheumatology. 2024-06-01 - 5 citationsThe Annual Diagnostic Prevalence of Ankylosing Spondylitis and Axial Spondyloarthritis in the United States Using Medicare and MarketScan DatabasesJeffrey R. Curtis, Kevin L. Winthrop, Rhonda L Bohn, Robert Suruki, Sarah A.R. Siegel
ACR Open Rheumatology. 2021-09-22 - Occurrence of Possible Rheumatologic Immune-Related Adverse Events (rh-irAEs) Associated with Immune Checkpoint Inhibitor (ICI) Therapy.Suzanne Anjohrin, Anna Sheahan, Robert Suruki, Jeffrey L Stark, Victor S. Sloan
Rheumatology and Therapy. 2021-09-07
Press Mentions
Non-Radiographic Axial Spondyloarthritis Recognized with ICD-10 CodeAugust 21st, 2020- UCB Announces U.S. Availability of BIMZELX® for the Treatment of Adults with Moderate-to-Severe Plaque PsoriasisNovember 16th, 2023
- Immunotherapy Now Available for Treating Moderate-to-Severe Plaque PsoriasisNovember 16th, 2023
Professional Memberships
- Fellow
Industry Relationships
- Head of Medical Affairs, Rheumatology, UCB, Inc.2014 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
